News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
96,753 Results
Type
Article (4517)
Company Profile (26)
Press Release (92209)
Multimedia
Podcasts (8)
Webinars (4)
Section
Business (32608)
Career Advice (319)
Deals (6791)
Drug Delivery (18)
Drug Development (8675)
Employer Resources (18)
FDA (2130)
Job Trends (2822)
News (50116)
Policy (3641)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Standard (2)
Academia (367)
Accelerated approval (9)
Adcomms (1)
Allergies (27)
Alliances (5724)
ALS (25)
Alzheimer's disease (179)
Antibody-drug conjugate (ADC) (36)
Approvals (2185)
Artificial intelligence (68)
Autoimmune disease (24)
Automation (8)
Bankruptcy (35)
Best Places to Work (2102)
BIOSECURE Act (5)
Biosimilars (15)
Biotechnology (16)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (81)
Cancer (631)
Cardiovascular disease (79)
Career advice (236)
Career pathing (3)
CAR-T (36)
CDC (3)
Cell therapy (88)
Cervical cancer (6)
Clinical research (7902)
Collaboration (213)
Compensation (169)
Complete response letters (7)
COVID-19 (313)
CRISPR (8)
C-suite (63)
Cystic fibrosis (22)
Data (1026)
Depression (22)
Dermatology (7)
Diabetes (57)
Diagnostics (1064)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (24)
Drug pricing (14)
Drug shortages (1)
Duchenne muscular dystrophy (56)
Earnings (22160)
Editorial (7)
Employer resources (17)
Events (12315)
Executive appointments (84)
FDA (2644)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (9)
Frontotemporal dementia (4)
Funding (224)
Gene editing (22)
Generative AI (2)
Gene therapy (91)
GLP-1 (124)
Government (547)
Grass and pollen (4)
Guidances (172)
Healthcare (3283)
HIV (15)
IgA nephropathy (16)
Immunology and inflammation (24)
Immuno-oncology (7)
Indications (14)
Infectious disease (350)
Inflammatory bowel disease (24)
Inflation Reduction Act (3)
Influenza (16)
Intellectual property (23)
Interviews (27)
IPO (4019)
IRA (4)
Job creations (766)
Job search strategy (215)
JPM (5)
Kidney cancer (5)
Labor market (25)
Layoffs (119)
Leadership (1)
Legal (797)
Liver cancer (16)
Longevity (1)
Lung cancer (83)
Lymphoma (56)
Machine learning (4)
Management (9)
Manufacturing (130)
MASH (29)
Medical device (2095)
Medtech (2104)
Mergers & acquisitions (2933)
Metabolic disorders (150)
mRNA (32)
Multiple sclerosis (15)
NASH (3)
Neurodegenerative disease (51)
Neuropsychiatric disorders (10)
Neuroscience (335)
NextGen: Class of 2026 (1060)
Non-profit (971)
Now hiring (9)
Obesity (51)
Opinion (50)
Ovarian cancer (13)
Pain (26)
Pancreatic cancer (32)
Parkinson's disease (42)
Partnered (4)
Patents (27)
Patient recruitment (39)
Peanut (13)
People (4774)
Pharmaceutical (10)
Pharmacy benefit managers (5)
Phase 1 (1906)
Phase 2 (3167)
Phase 3 (3309)
Pipeline (1405)
Policy (42)
Postmarket research (341)
Preclinical (736)
Press Release (14)
Prostate cancer (28)
Psychedelics (3)
Radiopharmaceuticals (24)
Rare diseases (176)
Real estate (1159)
Recruiting (7)
Regulatory (2879)
Reports (7)
Research institute (444)
Resumes & cover letters (84)
Rett syndrome (3)
RSV (8)
Schizophrenia (14)
Series A (32)
Series B (20)
Service/supplier (2)
Sickle cell disease (10)
Special edition (4)
Spinal muscular atrophy (13)
Sponsored (3)
Startups (400)
Supply chain (10)
Tariffs (17)
The Weekly (8)
Vaccines (137)
Venture capital (20)
Weight loss (33)
Women's health (11)
Date
Last 7 days (99)
Last 30 days (397)
Last 365 days (4424)
2026 (1140)
2025 (4428)
2024 (5057)
2023 (5966)
2022 (6731)
2021 (7479)
2020 (8350)
2019 (8142)
2018 (6308)
2017 (4779)
2016 (4214)
2015 (4968)
2014 (3442)
2013 (2763)
2012 (2982)
2011 (3321)
2010 (2845)
Location
Africa (107)
Alabama (13)
Alaska (2)
Arizona (38)
Arkansas (4)
Asia (5127)
Australia (711)
California (1832)
Canada (469)
China (178)
Colorado (109)
Connecticut (104)
Delaware (56)
Europe (13675)
Florida (259)
Georgia (40)
Idaho (7)
Illinois (167)
India (24)
Indiana (80)
Iowa (2)
Japan (83)
Kansas (18)
Kentucky (7)
Louisiana (12)
Maine (21)
Maryland (194)
Massachusetts (1097)
Michigan (33)
Minnesota (86)
Mississippi (1)
Missouri (43)
Montana (6)
Nebraska (1)
Nevada (7)
New Hampshire (12)
New Jersey (578)
New Mexico (3)
New York (495)
North Carolina (216)
Northern California (933)
Ohio (50)
Oklahoma (3)
Oregon (2)
Pennsylvania (399)
Puerto Rico (1)
Rhode Island (2)
South America (190)
South Carolina (5)
Southern California (722)
Tennessee (31)
Texas (299)
United States (6273)
Utah (58)
Vermont (1)
Virginia (28)
Washington D.C. (6)
Washington State (108)
Wisconsin (8)
Wyoming (1)
96,753 Results for "500".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
StairMed Secures RMB 500 Million Financing Led by Alibaba, Joined by Tencent
April 2, 2026
·
4 min read
Deals
Boehringer Seeks To Rebalance Immunity With Sitryx Collab Potentially Worth $500M+
While Boehringer Ingelheim hasn’t yet revealed what diseases it will go after, Sitryx’s oral drug candidate could potentially be disease-modifying for a variety of autoimmune and inflammatory conditions.
February 26, 2026
·
1 min read
·
Tristan Manalac
Press Releases
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million
March 19, 2026
·
13 min read
Manufacturing
J&J To Add 500 Jobs at New Plant, Doubling Down on North Carolina
Johnson & Johnson’s second facility in Wilson, North Carolina, is part of a $55 billion push to make all advanced medicines used in the U.S. domestically.
January 13, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000
March 10, 2026
·
4 min read
Press Releases
Nucleus Biologics Launches Krakatoa® K500: A Pod-Based, On-Demand Media and Buffer Manufacturing System Transforming Scale Bioproduction
February 11, 2026
·
4 min read
Press Releases
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
December 19, 2025
·
7 min read
Press Releases
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
December 2, 2025
·
2 min read
Press Releases
Summit Therapeutics Raises $500 Million in Private Placement
October 23, 2025
·
10 min read
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
The partners have yet to disclose what their priority indications are, though EVOQ’s NanoDisc technology aims to enable the development of potentially curative treatments for autoimmune conditions such as celiac disease and type 1 diabetes.
October 16, 2025
·
2 min read
·
Tristan Manalac
1 of 9,676
Next
